4.7 Article

B-Cell Very Late Antigen-4 Deficiency Reduces Leukocyte Recruitment and Susceptibility to Central Nervous System Autoimmunity

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

M. H. Barnett et al.

MULTIPLE SCLEROSIS JOURNAL (2012)

Article Medicine, General & Internal

B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis

Stephen L. Hauser et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Clinical Neurology

Immune surveillance in multiple sclerosis patients treated with natalizumab

O Stüve et al.

ANNALS OF NEUROLOGY (2006)

Article Clinical Neurology

Natalizumab effects on immune cell responses in multiple sclerosis

M Niino et al.

ANNALS OF NEUROLOGY (2006)

Article Medicine, General & Internal

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

CH Polman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2006)

Article Multidisciplinary Sciences

Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology

CB Marta et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Immunology

Determinants of human B cell migration across brain endothelial cells

A Alter et al.

JOURNAL OF IMMUNOLOGY (2003)

Article Biochemistry & Molecular Biology

Deletion of alpha 4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing

LM Scott et al.

MOLECULAR AND CELLULAR BIOLOGY (2003)

Article Medicine, Research & Experimental

Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis

BE Theien et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)